Eledon Pharmaceuticals
ELDN
ELDN
83 hedge funds and large institutions have $130M invested in Eledon Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 17 increasing their positions, 21 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
18% less capital invested
Capital invested by funds: $159M → $130M (-$28.3M)
19% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 21
87% less call options, than puts
Call options by funds: $36K | Put options by funds: $282K
Holders
83
Holding in Top 10
1
Calls
$36K
Puts
$282K
Top Buyers
| 1 | +$4.46M | |
| 2 | +$2.35M | |
| 3 | +$2.34M | |
| 4 |
2L
22NW LP
Seattle,
Washington
|
+$2.16M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$639K |
Top Sellers
| 1 | -$4.85M | |
| 2 | -$4.51M | |
| 3 | -$1M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$971K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$829K |